Oropharynx HPV-associated | Oropharynx HPV - | |||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Mean age | 1.02 (1.01–1.03) | < 0.001 | 1.01 (1.00–1.02) | < 0.001 |
Ethnicity | ||||
White | 1.00 | 1.00 | ||
Black | 0.86 (0.67–1.10) | 0.25 | 1.14 (1.01–1.30) | 0.03 |
American Indian/Eskimo | 0.61 (0.15–2.47) | 0.49 | 0.22 (0.03–1.58) | 0.13 |
Asian/Pacific Islander | 0.52 (0.24–1.10) | 0.09 | 0.75 (0.50–1.14) | 0.19 |
Other | 0.63 (0.15–2.52) | 0.51 | 1.29 (0.67–2.49) | 0.44 |
Sex | ||||
Men | 1.00 | 1.00 | ||
Women | 0.93 (0.79–1.09) | 0.412 | 1.15 (1.04–1.28) | 0.004 |
Charlson/Deyo Score | ||||
0 | 1.0 | 1.0 | ||
1 | 1.42 (1.23–1.65) | < 0.001 | 1.31 (1.17–1.46) | < 0.001 |
2 | 1.97 (1.56–2.48) | < 0.001 | 1.49 (1.25–1.77) | < 0.001 |
AJCC Clinical Staging | ||||
T Staging | ||||
T0 | 1.00 | 1.00 | ||
T1 | 2.61 (0.64–10.5) | 0.18 | 1.31 (0.32–5.30) | 0.70 |
T2 | 4.24 (1.05–17.0) | 0.04 | 1.93 (0.48–7.79) | 0.35 |
T3 | 6.47 (1.60–26.1) | 0.01 | 3.26 (0.81–13.1) | 0.10 |
T4 | 9.92 (2.45–40.0) | 0.00 | 4.35 (1.08–17.5) | 0.04 |
TX | 3.93 (0.93–16.4) | 0.06 | 2.65 (0.64–10.9) | 0.18 |
N Staging | ||||
N0 | 1.00 | 1.00 | ||
N1 | 0.81 (0.64–1.01) | 0.07 | 0.95 (0.82–1.10) | 0.53 |
N2 | 1.14 (0.95–1.37) | 0.14 | 1.10 (0.98–1.24) | 0.09 |
N3 | 2.06 (1.58–2.67) | < 0.001 | 1.76 (1.45–2.15) | < 0.001 |
NX | 0.73 (0.29–1.83) | 0.51 | 1.47 (0.91–2.36) | 0.11 |
Primary Site | ||||
Base of Tongue | 1.00 | 1.00 | ||
Tonsil | 1.03 (0.91–1.16) | 0.63 | 0.87 (0.79–0.96) | 0.01 |
Other OP | 1.48 (1.21–1.81) | < 0.001 | 1.15 (1.02–1.30) | 0.02 |
Insurance Status | ||||
Not Insured | 1.00 | 1.00 | ||
Private Insurance/Managed Care | 0.53 (0.41–0.68) | < 0.001 | 0.61 (0.51–0.72) | < 0.001 |
Medicaid | 1.04 (0.78–1.38) | 0.77 | 1.11 (0.93–1.34) | 0.23 |
Medicare | 0.99 (0.76–1.30) | 0.98 | 0.94 (0.78–1.13) | 0.55 |
Other Government | 0.96 (0.63–1.46) | 0.85 | 0.96 (0.67–1.36) | 0.83 |
Median Income Quartiles 2008–2012 | ||||
< $38,000 | 1.00 | 1.00 | ||
$38,000–$47,999 | 0.89 (0.75–1.06) | 0.21 | 0.9 (0.79–1.02) | 0.11 |
$48,000–$62,999 | 0.78 (0.65–0.93) | 0.01 | 0.83 (0.73–0.94) | 0.01 |
$63,000 + | 0.65 (0.54–0.77) | < 0.001 | 0.73 (0.64–0.83) | < 0.001 |
Treatment Group | ||||
No treatment | 1.00 | 1.00 | ||
Radiation only | 0.34 (0.24–0.48) | < 0.001 | 0.44 (0.35–0.54) | < 0.001 |
Radiation and Chemo | 0.22 (0.16–0.29) | < 0.001 | 0.27 (0.23–0.33) | < 0.001 |
Surgery and Radiation | 0.16 (0.10–0.24) | < 0.001 | 0.20 (0.14–0.28) | < 0.001 |
Surgery, Chemotherapy and Radiation | 0.21 (0.15–0.29) | < 0.001 | 0.29 (0.23–0.35) | < 0.001 |
Surgery only | 0.21 (0.14–0.32) | < 0.001 | 0.37 (0.29–0.47) | < 0.001 |
Chemotherapy Only | 1.08 (0.76–1.54) | 0.64 | 0.94 (0.76–1.18) | 0.64 |